TipRanks
Oncotelic Therapeutics (OTLC)
OTHER OTC:OTLC
US Market
OTLC
Oncotelic Therapeutics
RESEARCH TOOLSreports
Want to see OTLC full AI Analyst Report?

Oncotelic Therapeutics (OTLC) Ratios

86 Followers

Oncotelic Therapeutics Ratios

OTLC's free cash flow for Q2 2026 was $1.00. For the 2026 fiscal year, OTLC's free cash flow was decreased by $ and operating cash flow was $-3.37. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Dec 23Mar 23
Liquidity Ratios
Current Ratio
 0.08 0.07 <0.01 0.02 0.02
Quick Ratio
 0.08 0.07 <0.01 0.02 0.02
Cash Ratio
 0.01 <0.01 <0.01 0.01 0.01
Solvency Ratio
 <0.01 <0.01 -235.60 -0.43 1.05
Operating Cash Flow Ratio
 >-0.01 -0.08 -0.04 -0.08 -0.09
Short-Term Operating Cash Flow Coverage
 >-0.01 -0.08 -0.06 -0.12 -0.13
Net Current Asset Value
$ -10.00T>$ -10.00T>$ -19.07M$ -18.13M$ -16.62M
Leverage Ratios
Debt-to-Assets Ratio
 0.04 0.04 0.49 0.42 0.31
Debt-to-Equity Ratio
 0.06 0.06 1.59 1.04 0.58
Debt-to-Capital Ratio
 0.06 0.06 0.61 0.51 0.37
Long-Term Debt-to-Capital Ratio
 <0.01 0.00 0.00 0.14 0.00
Financial Leverage Ratio
 1.49 1.50 3.23 2.47 1.86
Debt Service Coverage Ratio
 -0.03 0.01 -0.25 -0.61 -0.39
Interest Coverage Ratio
 -5.25 -3.60 -4.17K -6.36 -3.27
Debt to Market Cap
 1.56M 492.95K 0.92 0.83 0.65
Interest Debt Per Share
 36.11K 38.65K 0.03 0.03 0.04
Net Debt to EBITDA
 -31.94 81.71 -3.67 -1.73 -1.97
Profitability Margins
Gross Profit Margin
100.00%0.00%0.00%100.00%0.00%
EBIT Margin
-2443.42%0.00%0.00%-10230.40%0.00%
EBITDA Margin
-199973738.60%0.00%0.00%-10230.39%0.00%
Operating Profit Margin
-2286.59%0.00%0.00%-9497.16%0.00%
Pretax Profit Margin
143532.19%0.00%0.00%-11722.95%0.00%
Net Profit Margin
98998.03%0.00%0.00%-11290.13%0.00%
Continuous Operations Profit Margin
98912.19%0.00%0.00%-11722.95%0.00%
Net Income Per EBT
68.97%69.13%100.00%96.31%381.04%
EBT Per EBIT
-6277.12%-11315.35%126.51%123.44%-48.11%
Return on Assets (ROA)
<0.01%<0.01%-16957.90%-26.33%49.34%
Return on Equity (ROE)
<0.01%<0.01%-54824.70%-65.15%91.81%
Return on Capital Employed (ROCE)
>-0.01%>-0.01%-47823.57%-49.21%-50.65%
Return on Invested Capital (ROIC)
>-0.01%>-0.01%-17388.34%-27.49%-31.93%
Return on Tangible Assets
<0.01%<0.01%-19852.75%-34.47%77.67%
Earnings Yield
2364.11%755.16%-31962.49%-52.15%103.10%
Efficiency Ratios
Receivables Turnover
 121.48 0.00 0.00 3.69 0.00
Payables Turnover
 0.00 0.00 0.00 0.00 <0.01
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 <0.01 0.00 0.00 <0.01 0.00
Working Capital Turnover Ratio
 >-0.01 0.00 0.00 >-0.01 0.00
Cash Conversion Cycle
 3.00 0.00 0.00 98.95 -49.34K
Days of Sales Outstanding
 3.00 0.00 0.00 98.95 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 0.00 0.00 0.00 0.00 49.34K
Operating Cycle
 3.00 0.00 0.00 98.95 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 -3.29K >-0.01 >-0.01 >-0.01
Free Cash Flow Per Share
 >-0.01 -3.29K >-0.01 >-0.01 >-0.01
CapEx Per Share
 <0.01 0.00 <0.01 <0.01 0.00
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -190.56K 0.00 -246.76K -440.35K 0.00
Capital Expenditure Coverage Ratio
 -190.56K 0.00 -246.76K -440.35K 0.00
Operating Cash Flow Coverage Ratio
 >-0.01 -0.08 -0.06 -0.11 -0.13
Operating Cash Flow to Sales Ratio
 -6.10 0.00 0.00 -18.87 0.00
Free Cash Flow Yield
-14.69%-4190077.95%-5.23%-8.72%-8.40%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 0.04 0.13 -3.13 -1.92 0.97
Price-to-Sales (P/S) Ratio
 41.52 0.00 0.00 216.48 0.00
Price-to-Book (P/B) Ratio
 <0.01 <0.01 1.72 1.25 0.89
Price-to-Free Cash Flow (P/FCF) Ratio
 -6.81 >-0.01 -19.12 -11.47 -11.90
Price-to-Operating Cash Flow Ratio
 -6.87 >-0.01 -19.12 -11.47 -11.90
Price-to-Earnings Growth (PEG) Ratio
 <0.01 >-0.01 0.07 0.01 >-0.01
Price-to-Fair Value
 <0.01 <0.01 1.72 1.25 0.89
Enterprise Value Multiple
 -31.94 81.71 -7.66 -3.85 -5.06
Enterprise Value
 15.97T 16.18T 27.16M 27.56M 28.30M
EV to EBITDA
 -31.94 81.71 -7.66 -3.85 -5.06
EV to Sales
 63.88M 0.00 0.00 393.67 0.00
EV to Free Cash Flow
 -10.48M -11.70 -36.68 -20.86 -19.48
EV to Operating Cash Flow
 -10.48M -11.70 -36.68 -20.86 -19.48
Tangible Book Value Per Share
 582.61K 615.00K <0.01 0.01 0.02
Shareholders’ Equity Per Share
 591.35K 624.07K 0.02 0.03 0.05
Tax and Other Ratios
Effective Tax Rate
 0.31 0.31 0.00 0.00 0.00
Revenue Per Share
 <0.01 0.00 0.00 <0.01 0.00
Net Income Per Share
 0.55 0.59 -11.19 -0.02 0.05
Tax Burden
 0.69 0.69 1.00 0.96 3.81
Interest Burden
 -58.74 -113.15 1.15K 1.15 -0.83
Research & Development to Revenue
 21.99K 0.00 0.00 0.87 0.00
SG&A to Revenue
 24.51M 0.00 0.00 8.20 0.00
Stock-Based Compensation to Revenue
 19.00M 0.00 0.00 0.00 0.00
Income Quality
 >-0.01 >-0.01 1.13 0.17 -0.31
Currency in USD